{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000179.4:c.2091G>A",
          "cDNA Change": {
            "transcript": "NM_000179.4",
            "ref": "G",
            "alt": "A",
            "position": "2091"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "697"
          },
          "Description in input context": "SNCA p.Ala697Thr (c.2091G>A) causes altered protein folding"
        },
        {
          "HGVS": "NM_000179.4:c.1294A>T",
          "cDNA Change": {
            "transcript": "NM_000179.4",
            "ref": "A",
            "alt": "T",
            "position": "1294"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "431"
          },
          "Description in input context": "SNCA p.Val431Met (c.1294A>T) demonstrates loss of proteasomal degradation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Multiple System Atrophy (MSA)",
    "MONDO": "MONDO:0005415"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunofluorescence Microscopy",
      "Material used": {
        "Material Source": "Human Post-Mortem Brain Tissue",
        "Material Name": "Brain Tissue from MSA patients and controls",
        "Description": "Immunofluorescence was performed on post-mortem brain tissue from patients diagnosed with MSA, and age-matched controls."
      },
      "Readout type": "Qualitative/Semi-Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000179.4:c.2091G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered Protein Conformation",
          "Result Description": "SNCA p.Ala697Thr showed increased aggregation and altered cellular localization in MSA brains compared to controls."
        },
        {
          "Variant": "NM_000179.4:c.1294A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced Proteasomal Degradation",
          "Result Description": "SNCA p.Val431Met showed reduced levels of proteasomal degradation, suggesting accumulation of the mutant protein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The experiment was repeated with brain tissue from five independent MSA patients and five age-matched controls."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was processed and imaged three times independently."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Commercially available antibodies for α-synuclein and ubiquitin were used as positive controls."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "An isotype control antibody was used to assess non-specific binding."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-tailed t-test was used to compare signal intensity between MSA patients and controls."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "α-synuclein aggregation score less than 2.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "α-synuclein aggregation score greater than 5.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}